Lynsey M. Cree
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lynsey M. Cree has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- David C. Samuels
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA
5 shared publications Elizabeth R. Hammond
Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
5 shared publications- Andrew Neil Shelling
Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland 1142, New Zealand
4 shared publications John C. Peek
Fertility Associates, Auckland, New Zealand
4 shared publicationsPatrick F. Chinnery
4 shared publications- Patrick Francis Chinnery
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
4 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 32 (5) , 613-636
Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review
BACKGROUND: Over the past decade, extracellular vesicles (EVs) released from embryos have received increasing attention for their potential role in influencing embryo–maternal communication events during implantation. Several studies have explored the relationship between embryo-derived EVs and embryo developmental competence. To synthesize current insights, we conducted a systematic review of the literature, highlighting key findings and evaluating how embryo EV profiles relate to embryo developmental competence. OBJECTIVE AND RATIONALE: A systematic review was conducted in accordance with the PRISMA guidelines. The review intended to (i) synthesize the existing knowledge on embryo-derived EV concentration, size, and cargo and their association with embryo developmental competence in mammalian systems, (ii) propose recommendations for future research, and (iii) assess the potential impact of the current literature on embryo selection during IVF. SEARCH METHODS: A literature search was performed across five databases (MEDLINE, EMBASE, BIOSIS Previews, Web of Science, and Scopus), involving keywords ‘Embryo’ AND ‘Extracellular vesicle’; many synonyms were included for each keyword along with map terms when available. The search was conducted on 14 January 2026. References were screened for additional relevant records. Abstract-only authors were contacted to determine whether full-text was available. The inclusion criteria were ‘collection of culture media from embryos of any mammalian species and isolation and assessment of EVs from it’. Reasons for exclusion included: ‘No collection of embryo culture media’, ‘No characterisation or assessment of EVs’, ‘Not embryo-derived EVs’, and ‘Review/Theory/Lacking primary data’. OUTCOMES: Our searches collected a total of 15 620 records; of these, 32 studies from 34 records were included in the systematic review. The included studies were divided into two groups: (i) studies of embryonic EV characteristics and (ii) studies that investigated the association of embryonic EV characteristics and embryo developmental competence, including embryo quality assessments based on morphology, ploidy, and pregnancy. Wide variations in embryo EV concentration and size were reported, largely due to differences in study designs. Overall, the quality of the existing literature ranged from low to moderate quality. Among the three human and eight bovine studies that examined the association of embryo EV concentration, size, and/or cargo with developmental competence, the certainty of the evidence for all outcomes was consistently very low. Studies often reported opposing directions of effects, whilst others showed no clear association. Inconsistencies in EV isolation techniques, timing of EV sampling, and methods for embryo quality assessments complicate efforts to assess whether embryonic EVs can be used as a reliable biomarker. WIDER IMPLICATIONS: Current evidence does not support the use of embryo EVs as biomarkers during IVF procedures. To enhance reproducibility and the production of high-quality studies, it is recommended that studies incorporate standardized approaches to EV isolation and characterization to align with best practices. In addition, the timing of EV sampling should be standardized, appropriate media controls used, and optimal measures of developmental competence, such as live birth, reported. Adherence to these recommendations will enable future studies to build constructively on the existing literature, with the possibility of informing clinical applications that improve patient outcomes. REGISTRATION NUMBER: https://doi.org/10.17605/OSF.IO/TPXVU
- 21 May 2026
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 32 (5) , 613-636
Open AccessEmbryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review
BACKGROUND: Over the past decade, extracellular vesicles (EVs) released from embryos have received increasing attention for their potential role in influencing embryo–maternal communication events during implantation. Several studies have explored the relationship between embryo-derived EVs and embryo developmental competence. To synthesize current insights, we conducted a systematic review of the literature, highlighting key findings and evaluating how embryo EV profiles relate to embryo developmental competence. OBJECTIVE AND RATIONALE: A systematic review was conducted in accordance with the PRISMA guidelines. The review intended to (i) synthesize the existing knowledge on embryo-derived EV concentration, size, and cargo and their association with embryo developmental competence in mammalian systems, (ii) propose recommendations for future research, and (iii) assess the potential impact of the current literature on embryo selection during IVF. SEARCH METHODS: A literature search was performed across five databases (MEDLINE, EMBASE, BIOSIS Previews, Web of Science, and Scopus), involving keywords ‘Embryo’ AND ‘Extracellular vesicle’; many synonyms were included for each keyword along with map terms when available. The search was conducted on 14 January 2026. References were screened for additional relevant records. Abstract-only authors were contacted to determine whether full-text was available. The inclusion criteria were ‘collection of culture media from embryos of any mammalian species and isolation and assessment of EVs from it’. Reasons for exclusion included: ‘No collection of embryo culture media’, ‘No characterisation or assessment of EVs’, ‘Not embryo-derived EVs’, and ‘Review/Theory/Lacking primary data’. OUTCOMES: Our searches collected a total of 15 620 records; of these, 32 studies from 34 records were included in the systematic review. The included studies were divided into two groups: (i) studies of embryonic EV characteristics and (ii) studies that investigated the association of embryonic EV characteristics and embryo developmental competence, including embryo quality assessments based on morphology, ploidy, and pregnancy. Wide variations in embryo EV concentration and size were reported, largely due to differences in study designs. Overall, the quality of the existing literature ranged from low to moderate quality. Among the three human and eight bovine studies that examined the association of embryo EV concentration, size, and/or cargo with developmental competence, the certainty of the evidence for all outcomes was consistently very low. Studies often reported opposing directions of effects, whilst others showed no clear association. Inconsistencies in EV isolation techniques, timing of EV sampling, and methods for embryo quality assessments complicate efforts to assess whether embryonic EVs can be used as a reliable biomarker. WIDER IMPLICATIONS: Current evidence does not support the use of embryo EVs as biomarkers during IVF procedures. To enhance reproducibility and the production of high-quality studies, it is recommended that studies incorporate standardized approaches to EV isolation and characterization to align with best practices. In addition, the timing of EV sampling should be standardized, appropriate media controls used, and optimal measures of developmental competence, such as live birth, reported. Adherence to these recommendations will enable future studies to build constructively on the existing literature, with the possibility of informing clinical applications that improve patient outcomes. REGISTRATION NUMBER: https://doi.org/10.17605/OSF.IO/TPXVU
- Open Access
Accurate Machine Learning Model for Human Embryo Morphokinetic Stage Detection
Purpose: The ability to detect, monitor, and precisely time the morphokinetic stages of human pre -implantation embryo development plays a critical role in assessing their viability and potential for successful implantation. Therefore, there is a need for accurate and accessible tools to analyse embryos. This work describes a highly accurate, machine learning model designed to predict 17 morphokinetic stages of pre-implantation human development, an improvement on existing models. This model provides a robust tool for researchers and clinicians, enabling the automation of morphokinetic stage prediction, standardising the process, and reducing subjectivity between clinics. Method: A computer vision model was built on a publicly available dataset for embryo Morphokinetic stage detection. The dataset contained 273,438 labelled images based on Embryoscope/+© embryo images. The dataset was split 70/10/20 into training/validation/test sets. Two different deep learning architectures were trained and tested, one using EfficientNet-V2-Large and the other using EfficientNet-V2-Large with the addition of fertilisation time as input. A new postprocessing algorithm was developed to reduce noise in the predictions of the deep learning model and detect the exact time of each morphokinetic stage change. Results: The proposed model reached an overall test accuracy of 87% across 17 morphokinetic stages on an independent test set. Conclusion: The proposed model shows a 17% accuracy improvement, compared to the best models on the same dataset. Therefore, our model can accurately detect morphokinetic stages in static embryo images as well as detecting the exact timings of stage changes in a complete time-lapse video.
Open AccessAccurate Machine Learning Model for Human Embryo Morphokinetic Stage Detection
Purpose: The ability to detect, monitor, and precisely time the morphokinetic stages of human pre -implantation embryo development plays a critical role in assessing their viability and potential for successful implantation. Therefore, there is a need for accurate and accessible tools to analyse embryos. This work describes a highly accurate, machine learning model designed to predict 17 morphokinetic stages of pre-implantation human development, an improvement on existing models. This model provides a robust tool for researchers and clinicians, enabling the automation of morphokinetic stage prediction, standardising the process, and reducing subjectivity between clinics. Method: A computer vision model was built on a publicly available dataset for embryo Morphokinetic stage detection. The dataset contained 273,438 labelled images based on Embryoscope/+© embryo images. The dataset was split 70/10/20 into training/validation/test sets. Two different deep learning architectures were trained and tested, one using EfficientNet-V2-Large and the other using EfficientNet-V2-Large with the addition of fertilisation time as input. A new postprocessing algorithm was developed to reduce noise in the predictions of the deep learning model and detect the exact time of each morphokinetic stage change. Results: The proposed model reached an overall test accuracy of 87% across 17 morphokinetic stages on an independent test set. Conclusion: The proposed model shows a 17% accuracy improvement, compared to the best models on the same dataset. Therefore, our model can accurately detect morphokinetic stages in static embryo images as well as detecting the exact timings of stage changes in a complete time-lapse video.
- Open Access
- 12 May 2023
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 29 (6)
Androgen signalling in the ovaries and endometrium
Currently, our understanding of hormonal regulation within the female reproductive system is largely based on our knowledge of estrogen and progesterone signalling. However, while the important functions of androgens in male physiology are well known, it is also recognized that androgens play critical roles in the female reproductive system. Further, androgen signalling is altered in a variety of gynaecological conditions, including endometriosis and polycystic ovary syndrome, indicative of regulatory roles in endometrial and ovarian function. Co-regulatory mechanisms exist between different androgens, estrogens, and progesterone, resulting in a complex network of steroid hormone interactions. Evidence from animal knockout studies, in vitro experiments, and human data indicate that androgen receptor expression is cell-specific and menstrual cycle stage-dependent, with important regulatory roles in the menstrual cycle, endometrial biology, and follicular development in the ovaries. This review will discuss the expression and co-regulatory interactions of androgen receptors, highlighting the complexity of the androgen signalling pathway in the endometrium and ovaries, and the synthesis of androgens from additional alternative pathways previously disregarded as male-specific. Moreover, it will illustrate the challenges faced when studying androgens in female biology, and the need for a more in-depth, integrative view of androgen metabolism and signalling in the female reproductive system.
- 12 May 2023
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 29 (6)
Open AccessAndrogen signalling in the ovaries and endometrium
Currently, our understanding of hormonal regulation within the female reproductive system is largely based on our knowledge of estrogen and progesterone signalling. However, while the important functions of androgens in male physiology are well known, it is also recognized that androgens play critical roles in the female reproductive system. Further, androgen signalling is altered in a variety of gynaecological conditions, including endometriosis and polycystic ovary syndrome, indicative of regulatory roles in endometrial and ovarian function. Co-regulatory mechanisms exist between different androgens, estrogens, and progesterone, resulting in a complex network of steroid hormone interactions. Evidence from animal knockout studies, in vitro experiments, and human data indicate that androgen receptor expression is cell-specific and menstrual cycle stage-dependent, with important regulatory roles in the menstrual cycle, endometrial biology, and follicular development in the ovaries. This review will discuss the expression and co-regulatory interactions of androgen receptors, highlighting the complexity of the androgen signalling pathway in the endometrium and ovaries, and the synthesis of androgens from additional alternative pathways previously disregarded as male-specific. Moreover, it will illustrate the challenges faced when studying androgens in female biology, and the need for a more in-depth, integrative view of androgen metabolism and signalling in the female reproductive system.
- 1 January 2017
- Published by Elsevier in Fertility and Sterility
- Vol. 107 (1) , 220-228.e5
Characterizing nuclear and mitochondrial DNA in spent embryo culture media: genetic contamination identified
- 1 January 2017
- Published by Elsevier in Fertility and Sterility
- Vol. 107 (1) , 220-228.e5
Characterizing nuclear and mitochondrial DNA in spent embryo culture media: genetic contamination identified
- Open Access
- 6 June 2016
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 31 (8) , 1653-1661
Nuclear and mitochondrial DNA in blastocoele fluid and embryo culture medium: evidence and potential clinical use
The ability to screen embryos for aneuploidy or inherited disorders in a minimally invasive manner may represent a major advancement for the future of embryo viability assessment. Recent studies have demonstrated that both blastocoele fluid and embryo culture medium contain genetic material, which can be isolated and subjected to downstream genetic analysis. The blastocoele fluid may represent an alternative source of nuclear DNA for aneuploidy testing, although the degree to which the isolated genetic material is solely representative of the developing embryo is currently unclear. In addition to nuclear DNA, mitochondrial DNA (mtDNA) can be detected in the embryo culture medium. Currently, the origin of this nuclear and mtDNA has not been fully evaluated and there are several potential sources of contamination that may contribute to the genetic material detected in the culture medium. There is however evidence that the mtDNA content of the culture medium is related to embryo fragmentation levels and its presence is predictive of blastulation, indicating that embryo development may influence the levels of genetic material detected. If the levels of genetic material are strongly related to aspects of embryo quality, then this may be a novel biomarker of embryo viability. If the genetic material does have an embryo origin, the mechanisms by which DNA may be released into the blastocoele fluid and embryo culture medium are unknown, although apoptosis may play a role. While the presence of this genetic material is an exciting discovery, the DNA in the blastocoele fluid and embryo culture medium appears to be of low yield and integrity, which makes it challenging to study. Further research aimed at assessing the methodologies used for both isolating and analysing this genetic material, as well as tracing its origin, are needed in order to evaluate its potential for clinical use. Should such methodologies prove to be routinely successful and the DNA recovered demonstrated to be embryonic in origin, then they may be used in a minimally invasive and less technical methodology for genetic analysis and embryo viability assessment than those currently available.
- 6 June 2016
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 31 (8) , 1653-1661
Open AccessNuclear and mitochondrial DNA in blastocoele fluid and embryo culture medium: evidence and potential clinical use
The ability to screen embryos for aneuploidy or inherited disorders in a minimally invasive manner may represent a major advancement for the future of embryo viability assessment. Recent studies have demonstrated that both blastocoele fluid and embryo culture medium contain genetic material, which can be isolated and subjected to downstream genetic analysis. The blastocoele fluid may represent an alternative source of nuclear DNA for aneuploidy testing, although the degree to which the isolated genetic material is solely representative of the developing embryo is currently unclear. In addition to nuclear DNA, mitochondrial DNA (mtDNA) can be detected in the embryo culture medium. Currently, the origin of this nuclear and mtDNA has not been fully evaluated and there are several potential sources of contamination that may contribute to the genetic material detected in the culture medium. There is however evidence that the mtDNA content of the culture medium is related to embryo fragmentation levels and its presence is predictive of blastulation, indicating that embryo development may influence the levels of genetic material detected. If the levels of genetic material are strongly related to aspects of embryo quality, then this may be a novel biomarker of embryo viability. If the genetic material does have an embryo origin, the mechanisms by which DNA may be released into the blastocoele fluid and embryo culture medium are unknown, although apoptosis may play a role. While the presence of this genetic material is an exciting discovery, the DNA in the blastocoele fluid and embryo culture medium appears to be of low yield and integrity, which makes it challenging to study. Further research aimed at assessing the methodologies used for both isolating and analysing this genetic material, as well as tracing its origin, are needed in order to evaluate its potential for clinical use. Should such methodologies prove to be routinely successful and the DNA recovered demonstrated to be embryonic in origin, then they may be used in a minimally invasive and less technical methodology for genetic analysis and embryo viability assessment than those currently available.
- 25 January 2016
- Published by Oxford University Press (OUP) in Genetics
- Vol. 202 (3) , 931-944
Segregation of Naturally Occurring Mitochondrial DNA Variants in a Mini-Pig Model
The maternally inherited mitochondrial genome (mtDNA) is present in multimeric form within cells and harbors sequence variants (heteroplasmy). While a single mtDNA variant at high load can cause disease, naturally occurring variants likely persist at low levels across generations of healthy populations. To determine how naturally occurring variants are segregated and transmitted, we generated a mini-pig model, which originates from the same maternal ancestor. Following next-generation sequencing, we identified a series of low-level mtDNA variants in blood samples from the female founder and her daughters. Four variants, ranging from 3% to 20%, were selected for validation by high-resolution melting analysis in 12 tissues from 31 animals across three generations. All four variants were maintained in the offspring, but variant load fluctuated significantly across the generations in several tissues, with sex-specific differences in heart and liver. Moreover, variant load was persistently reduced in high-respiratory organs (heart, brain, diaphragm, and muscle), which correlated significantly with higher mtDNA copy number. However, oocytes showed increased heterogeneity in variant load, which correlated with increased mtDNA copy number during in vitro maturation. Altogether, these outcomes show that naturally occurring mtDNA variants segregate and are maintained in a tissue-specific manner across generations. This segregation likely involves the maintenance of selective mtDNA variants during organogenesis, which can be differentially regulated in oocytes and preimplantation embryos during maturation.
- 25 January 2016
- Published by Oxford University Press (OUP) in Genetics
- Vol. 202 (3) , 931-944
Segregation of Naturally Occurring Mitochondrial DNA Variants in a Mini-Pig Model
The maternally inherited mitochondrial genome (mtDNA) is present in multimeric form within cells and harbors sequence variants (heteroplasmy). While a single mtDNA variant at high load can cause disease, naturally occurring variants likely persist at low levels across generations of healthy populations. To determine how naturally occurring variants are segregated and transmitted, we generated a mini-pig model, which originates from the same maternal ancestor. Following next-generation sequencing, we identified a series of low-level mtDNA variants in blood samples from the female founder and her daughters. Four variants, ranging from 3% to 20%, were selected for validation by high-resolution melting analysis in 12 tissues from 31 animals across three generations. All four variants were maintained in the offspring, but variant load fluctuated significantly across the generations in several tissues, with sex-specific differences in heart and liver. Moreover, variant load was persistently reduced in high-respiratory organs (heart, brain, diaphragm, and muscle), which correlated significantly with higher mtDNA copy number. However, oocytes showed increased heterogeneity in variant load, which correlated with increased mtDNA copy number during in vitro maturation. Altogether, these outcomes show that naturally occurring mtDNA variants segregate and are maintained in a tissue-specific manner across generations. This segregation likely involves the maintenance of selective mtDNA variants during organogenesis, which can be differentially regulated in oocytes and preimplantation embryos during maturation.
- Open Access
- 20 January 2016
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 22 (4) , 261-271
Oocyte mitochondrial deletions and heteroplasmy in a bovine model of ageing and ovarian stimulation
Maternal ageing and ovarian stimulation result in the accumulation of mitochondrial DNA (mtDNA) deletions and heteroplasmy in individual oocytes from a novel bovine model for human assisted reproductive technology (ART). The levels of mtDNA deletions detected in oocytes increased with ovarian ageing. Low levels of mtDNA heteroplasmy were apparent across oocytes and no relationship was identified with respect to ovarian ageing or ovarian stimulation. Oocyte quality decreases with ovarian ageing and it is postulated that the mtDNA may have a role in this decline. The impact of ovarian stimulation on oocyte quality is poorly understood. Human studies investigating these effects are often limited by the use of low quality oocytes and embryos, variation in age and ovarian stimulation regimens within the patients studied, as well as genetic and environmental variability. Further, no study has investigated mtDNA heteroplasmy in individual oocytes using next-generation sequencing (NGS), and little is known about whether the oocyte accumulates heteroplasmic mtDNA mutations following ageing or ovarian stimulation. A novel bovine model for the effect of stimulation and age in human ART was undertaken using cows generated by somatic cell nuclear transfer (SCNT) from one founder, to produce a homogeneous population with reduced genetic and environmental variability. Oocytes and somatic tissues were collected from young (3 years of age; n = 4 females) and old (10 years of age; n = 5 females) cow clones following multiple natural ovarian cycles, as well as oocytes following multiple mild (FSH only) and standard (based on human a long GnRH agonist protocol) ovarian stimulation cycles. In addition, oocytes were recovered in a natural cycle from naturally conceived cows aged 4–13.5 years (n = 10) to provide a heterogeneous cohort for mtDNA deletion studies. The presence or absence of mtDNA deletions were investigated using long-range PCR in individual oocytes (n = 62). To determine the detection threshold for mtDNA heteroplasmy levels in individual oocytes, a novel NGS methodology was validated; artificial mixtures of the Bos taurus and Bos indicus mitochondrial genome were generated at 1, 2, 5, 15 and 50% ratios to experimentally mimic different levels of heteroplasmy. This NGS methodology was then employed to determine mtDNA heteroplasmy levels in single oocytes (n = 24). Oocyte mtDNA deletion and heteroplasmy data were analysed by binary logistic regression with respect to the effects of ovarian ageing and ovarian stimulation regimens. Ovarian ageing, but not ovarian stimulation, increased the number of oocytes exhibiting mtDNA deletions (P = 0.04). A minimum mtDNA heteroplasmy level of 2% was validated as a sensitive (97–100%) threshold for variant detection in individual oocytes using NGS. Few mtDNA heteroplasmies were detected across the individual oocytes, with only 15 oocyte-specific variants confined to two of the 24 oocytes studied. There was no relationship (P > 0.05) evident between ovarian ageing or ovarian stimulation and the presence of mtDNA heteroplasmies. The low number of oocytes collected from the natural ovarian cycles limited the analysis. Fertilization and developmental potential of the oocytes was not assessed as the oocytes were destroyed for mtDNA deletion and heteroplasmy analysis. If the findings of this model apply to the human, this study suggests that the incidence of mtDNA deletions increases with age, but not with degree of ovarian stimulation, while the frequency of mtDNA heteroplasmies may be low regardless of ovarian ageing or level of ovarian stimulation. Funding was provided by Fertility Associates, the Nurture Foundation for Reproductive Research, the Fertility Society of Australia, and the Auckland Medical Research Foundation. J.C.P. is a shareholder of Fertility Associates and M.P.G. received a fellowship from Fertility Associates. The other authors of this manuscript declare no conflict of interest that could be perceived as prejudicing the impartiality of the reported research.
- 20 January 2016
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 22 (4) , 261-271
Open AccessOocyte mitochondrial deletions and heteroplasmy in a bovine model of ageing and ovarian stimulation
Maternal ageing and ovarian stimulation result in the accumulation of mitochondrial DNA (mtDNA) deletions and heteroplasmy in individual oocytes from a novel bovine model for human assisted reproductive technology (ART). The levels of mtDNA deletions detected in oocytes increased with ovarian ageing. Low levels of mtDNA heteroplasmy were apparent across oocytes and no relationship was identified with respect to ovarian ageing or ovarian stimulation. Oocyte quality decreases with ovarian ageing and it is postulated that the mtDNA may have a role in this decline. The impact of ovarian stimulation on oocyte quality is poorly understood. Human studies investigating these effects are often limited by the use of low quality oocytes and embryos, variation in age and ovarian stimulation regimens within the patients studied, as well as genetic and environmental variability. Further, no study has investigated mtDNA heteroplasmy in individual oocytes using next-generation sequencing (NGS), and little is known about whether the oocyte accumulates heteroplasmic mtDNA mutations following ageing or ovarian stimulation. A novel bovine model for the effect of stimulation and age in human ART was undertaken using cows generated by somatic cell nuclear transfer (SCNT) from one founder, to produce a homogeneous population with reduced genetic and environmental variability. Oocytes and somatic tissues were collected from young (3 years of age; n = 4 females) and old (10 years of age; n = 5 females) cow clones following multiple natural ovarian cycles, as well as oocytes following multiple mild (FSH only) and standard (based on human a long GnRH agonist protocol) ovarian stimulation cycles. In addition, oocytes were recovered in a natural cycle from naturally conceived cows aged 4–13.5 years (n = 10) to provide a heterogeneous cohort for mtDNA deletion studies. The presence or absence of mtDNA deletions were investigated using long-range PCR in individual oocytes (n = 62). To determine the detection threshold for mtDNA heteroplasmy levels in individual oocytes, a novel NGS methodology was validated; artificial mixtures of the Bos taurus and Bos indicus mitochondrial genome were generated at 1, 2, 5, 15 and 50% ratios to experimentally mimic different levels of heteroplasmy. This NGS methodology was then employed to determine mtDNA heteroplasmy levels in single oocytes (n = 24). Oocyte mtDNA deletion and heteroplasmy data were analysed by binary logistic regression with respect to the effects of ovarian ageing and ovarian stimulation regimens. Ovarian ageing, but not ovarian stimulation, increased the number of oocytes exhibiting mtDNA deletions (P = 0.04). A minimum mtDNA heteroplasmy level of 2% was validated as a sensitive (97–100%) threshold for variant detection in individual oocytes using NGS. Few mtDNA heteroplasmies were detected across the individual oocytes, with only 15 oocyte-specific variants confined to two of the 24 oocytes studied. There was no relationship (P > 0.05) evident between ovarian ageing or ovarian stimulation and the presence of mtDNA heteroplasmies. The low number of oocytes collected from the natural ovarian cycles limited the analysis. Fertilization and developmental potential of the oocytes was not assessed as the oocytes were destroyed for mtDNA deletion and heteroplasmy analysis. If the findings of this model apply to the human, this study suggests that the incidence of mtDNA deletions increases with age, but not with degree of ovarian stimulation, while the frequency of mtDNA heteroplasmies may be low regardless of ovarian ageing or level of ovarian stimulation. Funding was provided by Fertility Associates, the Nurture Foundation for Reproductive Research, the Fertility Society of Australia, and the Auckland Medical Research Foundation. J.C.P. is a shareholder of Fertility Associates and M.P.G. received a fellowship from Fertility Associates. The other authors of this manuscript declare no conflict of interest that could be perceived as prejudicing the impartiality of the reported research.
- Open Access
- 1 September 2015
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 7, 799-810
The genetics of premature ovarian failure: current perspectives
Premature ovarian failure (POF) is a common cause of infertility in women, characterized by amenorrhea, hypoestrogenism, and elevated gonadotropin levels in women under the age of 40. Many genes have been identified over the past few years that contribute to the development of POF. However, few genes have been identified that can explain a substantial proportion of cases of POF. The unbiased approaches of genome-wide association studies and next-generation sequencing technologies have identified several novel genes implicated in POF. As only a small proportion of genes influencing idiopathic POF have been identified thus far, it remains to be determined how many genes and molecular pathways may influence idiopathic POF development. However, owing to POF’s diverse etiology and genetic heterogeneity, we expect to see the contribution of several new and novel molecular pathways that will greatly enhance our understanding of the regulation of ovarian function. Future genetic studies in large cohorts of well-defined, unrelated, idiopathic POF patients will provide a great opportunity to identify the missing heritability of idiopathic POF. The identification of several causative genes may allow for early detection and would provide better opportunity for early intervention, and furthermore, the identification of specific gene defects will help direct potential targets for future treatment.
- 1 September 2015
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 7, 799-810
Open AccessThe genetics of premature ovarian failure: current perspectives
Premature ovarian failure (POF) is a common cause of infertility in women, characterized by amenorrhea, hypoestrogenism, and elevated gonadotropin levels in women under the age of 40. Many genes have been identified over the past few years that contribute to the development of POF. However, few genes have been identified that can explain a substantial proportion of cases of POF. The unbiased approaches of genome-wide association studies and next-generation sequencing technologies have identified several novel genes implicated in POF. As only a small proportion of genes influencing idiopathic POF have been identified thus far, it remains to be determined how many genes and molecular pathways may influence idiopathic POF development. However, owing to POF’s diverse etiology and genetic heterogeneity, we expect to see the contribution of several new and novel molecular pathways that will greatly enhance our understanding of the regulation of ovarian function. Future genetic studies in large cohorts of well-defined, unrelated, idiopathic POF patients will provide a great opportunity to identify the missing heritability of idiopathic POF. The identification of several causative genes may allow for early detection and would provide better opportunity for early intervention, and furthermore, the identification of specific gene defects will help direct potential targets for future treatment.
- 17 August 2015
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 31 (9) , 684-687
Discordant Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome in identical twins – a case report and implications for reproduction in MRKH women
(2015). Discordant Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome in identical twins – a case report and implications for reproduction in MRKH women. Gynecological Endocrinology: Vol. 31, No. 9, pp. 684-687. doi: 10.3109/09513590.2015.1032928
- 17 August 2015
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 31 (9) , 684-687
Discordant Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome in identical twins – a case report and implications for reproduction in MRKH women
(2015). Discordant Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome in identical twins – a case report and implications for reproduction in MRKH women. Gynecological Endocrinology: Vol. 31, No. 9, pp. 684-687. doi: 10.3109/09513590.2015.1032928